WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark CELLARES was filed as Word mark on 01/07/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1596887 |
| Countries | 
|
| Base trademark |
No. ,
July 12, 2024
|
| Application date | January 7, 2021 |
| Expiration date | January 7, 2031 |
Trademark owner
345 Allerton Ave
South San Francisco CA 94080
US
South San Francisco CA 94080
US
Trademark representatives
1299 Pennsylvania Avenue, NW,
Suite 700
US
goods and services
01
Chemical, biological and biochemical products for industrial
and scientific purposes, other than for medical purposes,
namely, biological tissue cultures for industrial and
scientific purposes and not for medical or veterinary
purposes; reagents for scientific and research use
09
Downloadable computer software for accessing a database
featuring information in the medical field, specifically,
stem cell therapy related information; downloadable software
applications for telephones, tablets, computers allowing the
access to information and consulting in the field of health;
downloadable software applications for telephones, tablets,
computers allowing the access to information, monitoring and
management systems for the manufacture of advanced therapy
and cell therapy medications; downloadable databases in the
field of manufacture of advanced therapy and cell therapy
medications; downloadable electronic publications in the
nature of electronic questionnaires on the area of advanced
therapy and cell therapy medications; none of the foregoing
in the field of pharmaceutical and veterinary products;
scientific apparatus and instruments for the manufacturing
of autologous and allogeneic biological cell therapies;
downloadable software for designing, executing, monitoring
and documenting the manufacturing processes for autologous
and allogeneic biological cell therapies; downloadable
software for automating the operations of biotechnological
instruments used with manufacturing equipment for biological
cell therapies; downloadable software for executing,
monitoring, and analyzing biological cell therapy
manufacturing workflows and process development workflows;
downloadable software for the processing, separating,
isolating, enriching, depleting, cell activating,
genetically modifying, expanding, formulating, harvesting,
detecting, screening, analyzing and counting of biological
material; downloadable software for generating electronic
batch records for biological cell therapies; scientific and
laboratory apparatus and instruments for the manufacturing
of autologous and allogeneic biological cell therapies in
the nature of laboratory centrifuges, cell sorting
apparatus, bioreactors for laboratory use, and parts and
fittings for all of the aforesaid goods; fully integrated
laboratory apparatus and computer systems for use in
biological cell therapy manufacturing, and parts and
fittings therefor
10
Medical equipment for the manufacturing of autologous and
allogeneic biological cell therapies for medical and
non-veterinary purposes, namely, fully integrated system for
use in the creation of biological cell therapies for medical
purposes; disposable single-use containers for solutions
used for the manufacturing of autologous and allogeneic
biological cell therapies, namely, bags, pouches,
cartridges, rigid and semi-rigid containers for concentrates
and solutions in solid or liquid form for medical use
37
Installation, repair and maintenance services of medical and
scientific apparatus and instruments for the manufacturing
of autologous and allogeneic biological cell therapies
38
Providing online forums in the field of manufacture of
advanced therapy and cell therapy medications for
discussion
40
Custom manufacture of therapeutic drugs, namely, custom
manufacture of cell therapies and cancer therapies; custom
manufacturing for others, namely, manufacturing of
pharmaceutical and veterinary preparations for health care,
for the treatment of humans and animals suffering from
diseases treated by cell therapy or regenerative medicine
products, particularly medicines for human purposes
including medicines for experimental purposes, biological
products for experimental purposes, preparations for cell
therapy and medicines for innovative therapies; custom
production of chemicals, ingredients for pharmaceuticals,
and biological cells for research and scientific purposes
for others; treatment of materials in the nature of
biological cells by means of processing them; manufacture of
reagents for biological cell therapies to the order and
specification of others
42
Research and development services in the field of cell
therapies; scientific research in human and animal cell
therapy; providing a bioinformatics platform as a service
(paas) featuring computer software for sequence data
analysis in the field of manufacturing therapeutics; medical
and scientific research information in the field of cell
therapy; medical and scientific research in the field of
cell therapy; technical assessments relating to design,
namely, technical design consultation in the field of
manufacture of advanced therapy and cell therapy
medications; technical research in the field of manufacture
of advanced therapy and cell therapy medications; software
as a service (saas) services featuring software for
assisting in the diagnosis of medical conditions in relation
to advanced therapy and cell therapy medications; cloud
computing featuring software for use in assisting in the
diagnosis of medical conditions; providing search engines
for the internet in the medical field and manufacturing of
advanced therapy and cell therapy medications fields;
computer services, namely, the creation for registered users
of virtual communities allowing the organization of groups
and events, the participation to discussion, and the
involvement into the social, business and community
networking in the medical field and manufacturing of
advanced therapy and cell therapy medications fields;
computer services, namely, electronic hosting of online web
facilities for the organization by third parties of
colloquiums, events and interactive discussions, via
communication networks in the medical field and
manufacturing of advanced therapy and cell therapy
medications fields; hosting digital content for users
account in the internet in the medical field and
manufacturing of advanced therapy and cell therapy
medications fields; designing online forums in the field of
manufacture of advanced therapy and cell; software as a
service (saas) services, namely, hosting software for use by
others for managing supply chains and logistics, tracking
and delivering custom cell and gene therapies; software as a
service (saas) services, namely, hosting software for use by
others for managing cold chain and vein-to-vein supply
chains and logistics, tracking and delivering custom cell
and gene therapies; software as a service (saas) services
featuring non-downloadable software for ordering, tracking,
scheduling, production, manufacturing, business
intelligence, and delivery of custom cell and gene
therapies; software as a service (saas) services featuring
software for the processing, separation, isolation,
enrichment, depletion, cell activation, genetic
modification, detection, screening, analysis and counting of
material
44
Stem cell therapy services; diagnostic and therapeutic
services in the field of genome sequencing and cell therapy,
namely, genetic testing of humans for health assessment,
diagnostic or treatment purposes; cell therapy services for
the treatment of hematological malignancies; administration
of cell therapy services for the treatment of hematological
malignancies; autologous and allogeneic biological cell
therapy services for medical treatment purposes
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 5, 2023 | 2023/19 Gaz | CH | Rejection |
| December 21, 2022 | 2022/52 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| October 13, 2022 | 2022/42 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| June 23, 2022 | 2022/26 Gaz | KR | Rejection |
| May 18, 2022 | 2022/20 Gaz | US | Correction |
| March 24, 2022 | 2022/12 Gaz | JP | Rejection |
| October 19, 2021 | 2021/43 Gaz | CN | Rejection |
| January 7, 2021 | 2021/22 Gaz | US | Registration |
ID: 141596887